Summary of the published Indian data on chronic myeloid leukemia.
Chronic myelogenous leukemia (LML) was recognized as a distinct entity in the mid-1800s. Since Nowell and Hunagerford initiated their research on CML in1960 our understanding in CML has been increasing. Imatinib became the preferred treatment from 2000 onwards as a result of its unprecedented success. The lack of structured Indian data on CML led to the formation of a CML data cansortuim which invited CML data albiet retro spartive form around the country including major cancer service providers both government and private. We provide a summary of published Indian data on CML here.
Department of Medical Oncology, Indraprastha Apollo Hospital, New Delhi, India.
Manish K
MK
Singhal
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Manju
M
Sengar
Tata Medical Center, Kolkata, West Bengal, India.
Reena
R
Nair
Chronic myeloid leukemia; Indian; published data